Hi, what are you looking for?
BLOG In the 2nd Aug 2015 edition of Israel’s good news, the highlights include: · Israeli scientists have turned stem cells into large...
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Allergan PLC, the Botox maker to treat wrinkles, agreed to buy Kythera Biopharmaceuticals Inc.,
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Could Valeant Be the hunted this year instead of the hunter?
DuPont CEO Ellen Kullman says DuPont's success has nothing to do with Trian's stake
Comparing Carl Icahn and Bill Ackman shows not all activist investing is created equal
In the annals of activist investing, 2014 was the year of Bill Ackman, but lacking enough dry powder, he might not be firing as...
The comparatively low level of cash assets currently held by hedge fund mogul Bill Ackman probably means that he won’t be making any activist...
Bill Ackman is doing something new and is getting behind another hedge besides his own, but it is still a hedge fund that is...